Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by bfw


T.TH

FYI...from NEJM today

The number of new HIV diagnoses has stalled, following 5 years of decline...

February 28, 2019

T.TH

RE:RE:Some thoughts

Cancer drugs have the lowest overall rate of success, with just 5.1 percent...

February 27, 2019

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Some thoughts

Ok....my last post on this as this is going in circles. Read this https...

February 27, 2019

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:Some thoughts

Yes, I understand that. I am also invested in BTI.V which uses a peptide...

February 26, 2019

T.TH

RE:RE:RE:RE:RE:RE:Some thoughts

Its all become more complicated with ADCs and peptides attached to previously...

February 26, 2019

T.TH

RE:RE:RE:RE:Some thoughts

Thankfully, the FDA will view the peptide linked to a conventional...

February 26, 2019

T.TH

RE:RE:Some thoughts

Good post. It took you a while to come around on NASH which I’ve been...

February 26, 2019

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Keeping all options open-

I agree that is the convention thinking. Anecdotally, Transglobe listed in...

February 26, 2019

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:Keeping all options open-

Yes, just get listed on the Nasdaq without an offering. Another one of my...

February 26, 2019

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:Mackie drops target to $9.60 on rising R&D costs

In other news... The market says to give Uddin’s analysis a pass :) bfw...

February 26, 2019

T.TH

RE:Mackie drops target to $9.60 on rising R&D costs

He (Uddin) seems disinterested and disorganized on the conference calls. On...

February 25, 2019

T.TH

RE:RE:RE:Katama Factsheet cached

I would not draw that conclusion. Basically, funding for small biotech in...

February 25, 2019

T.TH

RE:RE:RE:RE:RE:RE:RE:Buying a lottery ticket!!!

I think it another another piece of info that helps the sentiment towards TH....

February 25, 2019

T.TH

RE:RE:RE:RE:RE:Buying a lottery ticket!!!

Yes, I think the market is bidding up TH on this news for good reason. Many...

February 25, 2019

T.TH

RE:RE:TH buys Katana Biopharma

Interesting.....thought they would continue focus on HIV and infectious...

February 25, 2019

T.TH

RE:RE:RE:RE:RE:RE:F4 formulation

Yes, but even if NASH results are incredible, the reps can’t detail on that...

February 24, 2019

T.TH

RE:RE:RE:RE:RE:F4 formulation

Good point. Perhaps reps can point to the CDC as to why undetectable is the...

February 24, 2019

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RBC

I had a listen to that part of the webcast again. Marsolais does not...

February 23, 2019

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RBC

I will quibble with point A. Very good results + No extended patent + label...

February 23, 2019

T.TH

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RBC

SPCEO, Pleas review this presentation to see that Grinspoon designed an...

February 23, 2019

Featured Company